U.S. public company Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced that its board of directors approved the purchase of up to $1 million in bitcoin as a fiscal reserve asset. According to reports, Acurx Pharmaceuticals is a late-stage biopharmaceutical company.